See All Slides - tctmd.com

Slides

Presentation THT 2026

Experiences With Implant-Free Interatrial Shunting

Presenter: James E. Udelson

March 04, 2026

Presentation THT 2026

Design and Conduct of the INNOVATE Trial: Randomizing Durable LVAD Therapy in a High-Acuity Era

Presenter: Francis D. Pagani

March 04, 2026

Presentation THT 2026

Do We Need Shunts of Different Sizes?

Presenter: Liviu Klein

March 04, 2026

Presentation THT 2026

Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness

Presenter: Ryan J. Tedford

March 04, 2026

Presentation THT 2026

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

Presenter: Beth A. Davison

March 04, 2026

Presentation THT 2026

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Presenter: Makiko Nakamura

March 04, 2026

Presentation THT 2026

Evaluation of RV Function in Shunt Trials — Does it Matter?

Presenter: Joao L. Cavalcante

March 04, 2026

Presentation THT 2026

The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial

Presenter: Jeffrey Testani

March 04, 2026

Presentation THT 2026

Appraising the Risk of Harm in HFpEF and the Likelihood of Benefit in HFrEF

Presenter: Sheldon E. Litwin

March 04, 2026

Presentation THT 2026

THT Fellows Abstract Competition Winner Announcement

Presenter: Daniel Burkhoff

March 04, 2026

Advertisement

Slides

Experiences With Implant-Free Interatrial Shunting

Design and Conduct of the INNOVATE Trial: Randomizing Durable LVAD Therapy in a High-Acuity Era

Do We Need Shunts of Different Sizes?

Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Evaluation of RV Function in Shunt Trials — Does it Matter?

The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial

Appraising the Risk of Harm in HFpEF and the Likelihood of Benefit in HFrEF

THT Fellows Abstract Competition Winner Announcement

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content